Michela Piezzo

1.1k total citations
20 papers, 679 citations indexed

About

Michela Piezzo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Michela Piezzo has authored 20 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Michela Piezzo's work include Advanced Breast Cancer Therapies (6 papers), Cancer Treatment and Pharmacology (5 papers) and Breast Cancer Treatment Studies (5 papers). Michela Piezzo is often cited by papers focused on Advanced Breast Cancer Therapies (6 papers), Cancer Treatment and Pharmacology (5 papers) and Breast Cancer Treatment Studies (5 papers). Michela Piezzo collaborates with scholars based in Italy, France and United States. Michela Piezzo's co-authors include Michelino De Laurentiis, Roberta Caputo, Stefania Cocco, Vincenzo Di Lauro, Germira Di Gioia, Giuseppina Fusco, Daniela Cianniello, Francesco Nuzzo, Matilde Pensabene and Alfredo Budillon and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Michela Piezzo

19 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michela Piezzo Italy 11 279 245 235 174 90 20 679
Lihua Huang China 11 232 0.8× 293 1.2× 215 0.9× 117 0.7× 43 0.5× 23 709
Daichi Ishikawa Japan 20 289 1.0× 340 1.4× 120 0.5× 189 1.1× 109 1.2× 48 851
Silvia Ottaviani United Kingdom 15 217 0.8× 442 1.8× 104 0.4× 286 1.6× 98 1.1× 28 843
Michail Nikolaou Greece 13 318 1.1× 360 1.5× 113 0.5× 198 1.1× 106 1.2× 41 871
Federica Spadaccino Italy 11 222 0.8× 363 1.5× 197 0.8× 155 0.9× 47 0.5× 19 810
Xiaorong Yang China 20 271 1.0× 463 1.9× 255 1.1× 357 2.1× 54 0.6× 73 1.0k
Elisavet Paplomata United States 9 307 1.1× 359 1.5× 158 0.7× 142 0.8× 42 0.5× 14 708
Gregory H. Ripple United States 14 520 1.9× 272 1.1× 333 1.4× 152 0.9× 111 1.2× 22 978

Countries citing papers authored by Michela Piezzo

Since Specialization
Citations

This map shows the geographic impact of Michela Piezzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michela Piezzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michela Piezzo more than expected).

Fields of papers citing papers by Michela Piezzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michela Piezzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michela Piezzo. The network helps show where Michela Piezzo may publish in the future.

Co-authorship network of co-authors of Michela Piezzo

This figure shows the co-authorship network connecting the top 25 collaborators of Michela Piezzo. A scholar is included among the top collaborators of Michela Piezzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michela Piezzo. Michela Piezzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caputo, R., Michela Piezzo, Claudia von Arx, et al.. (2025). 354P Sacituzumab govitecan for the treatment of metastatic triple-negative breast cancer patients: A multicenter real-world updated analysis. ESMO Open. 10. 104925–104925. 1 indexed citations
2.
Buono, Giuseppe, Monica Capozzi, Roberta Caputo, et al.. (2024). CAR-T cell therapy for breast cancer: Current status and future perspective. Cancer Treatment Reviews. 133. 102868–102868. 7 indexed citations
3.
Caputo, Roberta, Giuseppe Buono, Michela Piezzo, et al.. (2024). Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis. Frontiers in Oncology. 14. 1362641–1362641. 29 indexed citations
4.
Cocco, Stefania, Alessandra Leone, Maria Serena Roca, et al.. (2022). Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models. Journal of Translational Medicine. 20(1). 290–290. 79 indexed citations
5.
Cozzolino, Mauro, Stefania Cocco, Michela Piezzo, et al.. (2021). A Psychosocial Genomics Pilot Study in Oncology for Verifying Clinical, Inflammatory and Psychological Effects of Mind-Body Transformations-Therapy (MBT-T) in Breast Cancer Patients: Preliminary Results. Journal of Clinical Medicine. 10(1). 136–136. 12 indexed citations
6.
7.
Piezzo, Michela, Roberta D’Aniello, Daniela Cianniello, et al.. (2021). Uptake of Trastuzumab Biosimilars for the Treatment of HER2-Positive Breast Cancer: A Real-World Experience from a Cancer Center. Pharmaceutics. 13(5). 684–684. 6 indexed citations
8.
Blondeaux, Eva, Luca Boni, Vincenzo Di Lauro, et al.. (2021). 307P Overall survival in metastatic breast cancer patients according to different follow up strategies for early breast cancer. Annals of Oncology. 32. S497–S498. 1 indexed citations
9.
Maraolo, Alberto Enrico, Anna Crispo, Michela Piezzo, et al.. (2021). The Use of Tocilizumab in Patients with COVID-19: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Studies. Journal of Clinical Medicine. 10(21). 4935–4935. 13 indexed citations
10.
Berretta, Massimiliano, Vincenzo Quagliariello, Nicola Maurea, et al.. (2020). Multiple Effects of Ascorbic Acid against Chronic Diseases: Updated Evidence from Preclinical and Clinical Studies. Antioxidants. 9(12). 1182–1182. 66 indexed citations
11.
Feo, Gianfranco De, Gerardo Botti, Arturo Capasso, et al.. (2020). Clinical trials and drug cost savings for Italian health service. BMC Health Services Research. 20(1). 1089–1089. 10 indexed citations
12.
Piezzo, Michela, Stefania Cocco, Roberta Caputo, et al.. (2020). Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors. International Journal of Molecular Sciences. 21(18). 6479–6479. 126 indexed citations
13.
Cocco, Stefania, Alessandra Leone, Michela Piezzo, et al.. (2020). Targeting Autophagy in Breast Cancer. International Journal of Molecular Sciences. 21(21). 7836–7836. 73 indexed citations
14.
Piezzo, Michela, Paolo Chiodini, Stefania Cocco, et al.. (2020). Progression-Free Survival and Overall Survival of CDK 4/6 Inhibitors Plus Endocrine Therapy in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 21(17). 6400–6400. 79 indexed citations
15.
Cocco, Stefania, Michela Piezzo, Alessandra Calabrese, et al.. (2020). Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives. International Journal of Molecular Sciences. 21(13). 4579–4579. 82 indexed citations
16.
17.
Mustacchi, Giorgio, P. Pronzato, Grazia Arpino, et al.. (2019). Triple-negative (TNBC) metastatic breast cancer (MBC) patients (pts): Is chemotherapy (CHT) choice influenced by adjuvant (adj) treatments? Results from the GIM-13 AMBRA study.. Journal of Clinical Oncology. 37(15_suppl). e12549–e12549. 2 indexed citations
18.
Caputo, Roberta, Daniela Cianniello, Michela Piezzo, et al.. (2019). Gene Expression Assay in the Management of Early Breast Cancer. Current Medicinal Chemistry. 27(17). 2826–2839. 9 indexed citations
19.
Cazzaniga, Marina Elena, P. Pronzato, Icro Meattini, et al.. (2018). Validation of time to treatment change (TTC) as a surrogate end-point of progression free survival (PFS) for observational trials in metastatic breast cancer patients (MBC): The GIM-13 AMBRA study.. Journal of Clinical Oncology. 36(15_suppl). e13081–e13081. 2 indexed citations
20.
Botti, Gerardo, Francesca Collina, Giosuè Scognamiglio, et al.. (2017). Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients. International Journal of Molecular Sciences. 18(2). 459–459. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lihua Huang Breakdown of academic impact, for papers by Daichi Ishikawa Breakdown of academic impact, for papers by Silvia Ottaviani Breakdown of academic impact, for papers by Michail Nikolaou Breakdown of academic impact, for papers by Federica Spadaccino Breakdown of academic impact, for papers by Xiaorong Yang Breakdown of academic impact, for papers by Elisavet Paplomata Breakdown of academic impact, for papers by Gregory H. Ripple
Rankless by CCL
2026